The Emerging Therapeutic Target of Dynamic and Reversible N6-methyladenosine Modification During Cancer Development

Overview

Journal Front Oncol

Specialty Oncology

Date 2022 Oct 13

PMID 36226062

Authors

Shougeng Liu

Sihong Chen

Chengfang Tang

Yingxi Zhao

Wei Cui

Lina Jia

Lihui Wang

Affiliations

Soon will be listed here.

Abstract

As a reversible and dynamic epigenetic modification, N6-methyladenosine (m6A) modification is ubiquitous in eukaryotic cells. m6A methylation is prevalent in almost all RNA metabolism processes that affect the fate of cells, including cancer development. As indicated by the available evidence, targeting m6A regulators may play a crucial role in tumor therapy and multidrug resistance. Currently, many questions remain uncovered. Here, we review recent studies on m6A modification in various aspects of tumor progression, tumor immunity, multidrug resistance, and therapeutic targets to provide new insight into the m6A methylation process.

Citing Articles

The role of genetic diversity, epigenetic regulation, and sex-based differences in HIV cure research: a comprehensive review.

Letchumanan P, Das K Epigenetics Chromatin. 2025; 18(1):1.

PMID: 39754177 PMC: 11697457. DOI: 10.1186/s13072-024-00564-4.

Mass Spectrometry-Based Pipeline for Identifying RNA Modifications Involved in a Functional Process: Application to Cancer Cell Adaptation.

Amalric A, Attina A, Bastide A, Buffard M, Mateus S, Planque C Anal Chem. 2024; 96(5):1825-1833.

PMID: 38275837 PMC: 10851184. DOI: 10.1021/acs.analchem.3c02635.

References

You Y, Fu Y, Huang M, Shen D, Zhao B, Liu H . Recent Advances of m6A Demethylases Inhibitors and Their Biological Functions in Human Diseases. Int J Mol Sci. 2022; 23(10). PMC: 9144293. DOI: 10.3390/ijms23105815. View

Liu Z, Zhong J, Zeng J, Duan X, Lu J, Sun X . Characterization of the m6A-Associated Tumor Immune Microenvironment in Prostate Cancer to Aid Immunotherapy. Front Immunol. 2021; 12:735170. PMC: 8438522. DOI: 10.3389/fimmu.2021.735170. View

Chen M, Wei L, Law C, Tsang F, Shen J, Cheng C . RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology. 2017; 67(6):2254-2270. DOI: 10.1002/hep.29683. View

Lederer M, Bley N, Schleifer C, Huttelmaier S . The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer. Semin Cancer Biol. 2014; 29:3-12. DOI: 10.1016/j.semcancer.2014.07.006. View

Wang R, Li J, Bao B, Wu H, Du Z, Su J . MicroRNA-873 (miRNA-873) inhibits glioblastoma tumorigenesis and metastasis by suppressing the expression of IGF2BP1. J Biol Chem. 2015; 290(14):8938-48. PMC: 4423684. DOI: 10.1074/jbc.M114.624700. View

Sabnis R . Novel Small Molecule RNA m6A Demethylase AlkBH5 Inhibitors for Treating Cancer. ACS Med Chem Lett. 2021; 12(6):856-857. PMC: 8201485. DOI: 10.1021/acsmedchemlett.1c00102. View

Jin D, Guo J, Wu Y, Du J, Yang L, Wang X . mA mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis. J Hematol Oncol. 2021; 14(1):32. PMC: 7901070. DOI: 10.1186/s13045-021-01048-8. View

Chelmicki T, Roger E, Teissandier A, Dura M, Bonneville L, Rucli S . mA RNA methylation regulates the fate of endogenous retroviruses. Nature. 2021; 591(7849):312-316. DOI: 10.1038/s41586-020-03135-1. View

Hsu P, Zhu Y, Ma H, Guo Y, Shi X, Liu Y . Ythdc2 is an N-methyladenosine binding protein that regulates mammalian spermatogenesis. Cell Res. 2017; 27(9):1115-1127. PMC: 5587856. DOI: 10.1038/cr.2017.99. View

10.

Li W, Deng X, Chen J . RNA-binding proteins in regulating mRNA stability and translation: roles and mechanisms in cancer. Semin Cancer Biol. 2022; 86(Pt 2):664-677. PMC: 9526761. DOI: 10.1016/j.semcancer.2022.03.025. View

11.

Nie S, Zhang L, Liu J, Wan Y, Jiang Y, Yang J . ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer. J Exp Clin Cancer Res. 2021; 40(1):284. PMC: 8425158. DOI: 10.1186/s13046-021-02088-1. View

12.

Liu Y, Liang G, Xu H, Dong W, Dong Z, Qiu Z . Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance. Cell Metab. 2021; 33(6):1221-1233.e11. DOI: 10.1016/j.cmet.2021.04.001. View

13.

Huang H, Weng H, Chen J . mA Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer. Cancer Cell. 2020; 37(3):270-288. PMC: 7141420. DOI: 10.1016/j.ccell.2020.02.004. View

14.

Ma L, Chen T, Zhang X, Miao Y, Tian X, Yu K . The mA reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function. Redox Biol. 2020; 38:101801. PMC: 7691619. DOI: 10.1016/j.redox.2020.101801. View

15.

Zhou T, Li S, Xiang D, Liu J, Sun W, Cui X . m6A RNA methylation-mediated HNF3γ reduction renders hepatocellular carcinoma dedifferentiation and sorafenib resistance. Signal Transduct Target Ther. 2020; 5(1):296. PMC: 7762754. DOI: 10.1038/s41392-020-00299-0. View

16.

Kandimalla R, Gao F, Li Y, Huang H, Ke J, Deng X . RNAMethyPro: a biologically conserved signature of N6-methyladenosine regulators for predicting survival at pan-cancer level. NPJ Precis Oncol. 2019; 3:13. PMC: 6494854. DOI: 10.1038/s41698-019-0085-2. View

17.

Deng S, Zhang H, Zhu K, Li X, Ye Y, Li R . M6A2Target: a comprehensive database for targets of m6A writers, erasers and readers. Brief Bioinform. 2020; 22(3). DOI: 10.1093/bib/bbaa055. View

18.

Zhou F, Wang D, Zhou N, Chen H, Shi H, Peng R . Circular RNA Protein Tyrosine Kinase 2 Promotes Cell Proliferation, Migration and Suppresses Apoptosis Activating MicroRNA-638 Mediated MEK/ERK, WNT/β-Catenin Signaling Pathways in Multiple Myeloma. Front Oncol. 2021; 11:648189. PMC: 8355695. DOI: 10.3389/fonc.2021.648189. View

19.

Barbieri I, Tzelepis K, Pandolfini L, Shi J, Millan-Zambrano G, Robson S . Promoter-bound METTL3 maintains myeloid leukaemia by mA-dependent translation control. Nature. 2017; 552(7683):126-131. PMC: 6217924. DOI: 10.1038/nature24678. View

20.

Wang S, Gao S, Zeng Y, Zhu L, Mo Y, Wong C . N6-Methyladenosine Reader YTHDF1 Promotes ARHGEF2 Translation and RhoA Signaling in Colorectal Cancer. Gastroenterology. 2021; 162(4):1183-1196. DOI: 10.1053/j.gastro.2021.12.269. View